Cancer study aims to tame treatment side effects with less medication
NCT ID NCT07167251
Summary
This study is testing whether a lower, starting dose of steroids (like prednisolone) is enough to treat liver inflammation that sometimes occurs as a side effect of modern cancer immunotherapies. It will involve about 63 adult cancer patients who develop this specific liver issue. The goal is to see if this approach controls the problem while causing fewer steroid-related side effects and without needing to stop the cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal Marsden Hospital
NOT_YET_RECRUITINGLondon, SW3 6JJ, United Kingdom
-
University Hospital Basel
RECRUITINGBasel, Canton of Basel-City, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.